A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine.
Aug 19, 2014
5 / 5 (4) | 0
(Medical Xpress)—Researchers at Roswell Park Cancer Institute (RPCI) have found that the expression pattern of a unique class of tumor-associated antigens, known as the MAGE cancer-testis antigens (CTAs), correlates with ...
Aug 14, 2014
5 / 5 (1) | 0